Xeris Biopharma Holdings Inc (XERS)
2.98
0.00 (0.00%)
USD |
NASDAQ |
Oct 04, 16:00
2.98
0.00 (0.00%)
Pre-Market: 20:00
Xeris Biopharma Holdings Shareholders Equity (Annual): -6.782M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -6.782M |
| December 31, 2022 | 45.19M |
| December 31, 2021 | 95.23M |
| December 31, 2020 | 33.76M |
| Date | Value |
|---|---|
| December 31, 2019 | 14.44M |
| December 31, 2018 | 75.41M |
| December 31, 2017 | -57.83M |
| December 31, 2016 | -31.93M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
-6.782M
Minimum
2023
95.23M
Maximum
2021
36.37M
Average
33.76M
Median
2020
Shareholders Equity (Annual) Benchmarks
| Zoetis Inc | 4.997B |
| Zevra Therapeutics Inc | 61.86M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |